Details for: RPL21P19

Gene ID: 641293

Gene Type:  Pseudogene  - A non-functional segment of DNA that resembles a functional gene but has lost its protein-coding ability or is otherwise no longer expressed.

Symbol: RPL21P19

Ensembl ID: ENSG00000219133

Description: ribosomal protein L21 pseudogene 19

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 7.97
    rCSI 6.38%
    PRS 99.38

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.
Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [RPL21P19](/details-gene/641293) is a pseudogene located on chromosome 1q32.1, derived from the functional gene encoding ribosomal protein L21. While pseudogenes are often considered non-functional relics, the expression profile of [RPL21P19](/details-gene/641293) suggests a potentially specialized role. **Overall**, analysis indicates its most significant and specific expression occurs in [CD4-positive, alpha-beta thymocytes](/details-cell/CL0000810) (CSI: 7.97). This specific expression pattern in a key developmental T-cell population points towards a possible, non-canonical function in thymic T-cell maturation, distinguishing it from transcriptional noise. ## Cellular Roles and Expression Landscape The most striking feature of [RPL21P19](/details-gene/641293) is its highly localized expression profile. The available data identifies a single cell type where it is a significant marker: * **T-Cell Development:** The gene's expression is exceptionally high in [CD4-positive, alpha-beta thymocytes](/details-cell/CL0000810). These are immature T-cells within the thymus undergoing critical developmental processes, including positive and negative selection. The high significance (CSI: 7.97) suggests that while [RPL21P19](/details-gene/641293) is a pseudogene, its transcript may be abundant in this specific cellular context. Given its pseudogene status, this expression could be interpreted in several ways. It might represent a transcript with a novel regulatory function, such as a long non-coding RNA (lncRNA) that influences gene expression during T-cell development. Alternatively, its expression could be a byproduct of the open chromatin state at the parent `RPL21` locus, which is likely active in these highly proliferative and metabolically demanding cells. Without data on its expression in other cell types, its full specificity remains to be characterized, but the current evidence strongly ties it to T-cell biology. ## Pathways and Molecular Function Direct functional annotation for the [RPL21P19](/details-gene/641293) pseudogene is not available. However, its origin from the `RPL21` gene provides a strong clue to its potential biological context. The parent `RPL21` protein is a core component of the large 60S ribosomal subunit, which is fundamental to the process of mRNA translation and protein synthesis. Considering this, the transcript of [RPL21P19](/details-gene/641293) could play a regulatory role related to ribosome biogenesis or protein translation. Developing [CD4-positive, alpha-beta thymocytes](/details-cell/CL0000810) require robust protein synthesis to support their proliferation and differentiation. It is plausible that the [RPL21P19](/details-gene/641293) transcript acts as a competing endogenous RNA (ceRNA) or "miRNA sponge," sequestering microRNAs that would otherwise target the parent `RPL21` mRNA or other translation-related transcripts, thereby fine-tuning the rate of protein synthesis during this critical developmental window. ## Research Directions The specific expression of a pseudogene in a key immune cell precursor opens up several avenues for investigation. The central question is whether this expression is functional or merely correlational. ### Proposed Hypotheses 1. **Regulatory lncRNA Hypothesis:** The [RPL21P19](/details-gene/641293) transcript functions as a long non-coding RNA that regulates the expression of its parent gene, `RPL21`, or other genes critical for T-cell maturation in [CD4-positive, alpha-beta thymocytes](/details-cell/CL0000810). This regulation could be essential for controlling the rate of protein synthesis required for thymocyte selection and expansion. 2. **Biomarker Hypothesis:** The expression of [RPL21P19](/details-gene/641293) is non-functional but serves as a highly specific biomarker for a distinct metabolic or proliferative state of [CD4-positive, alpha-beta thymocytes](/details-cell/CL0000810) during their development, potentially marking cells that have successfully passed a key checkpoint. ### Experimental Approach To test the **Regulatory lncRNA Hypothesis**, a targeted knockdown experiment is warranted. * **Experiment:** Utilize CRISPR interference (CRISPRi) to specifically repress the transcription of the [RPL21P19](/details-gene/641293) locus in an *in vitro* model of human T-cell development, such as differentiating hematopoietic stem and progenitor cells (HSPCs) on an OP9-DL4 stromal layer. * **Analysis:** Following knockdown, assess the impact on thymocyte development using multi-parameter flow cytometry to quantify cell populations at different maturation stages (e.g., DN, DP, SP4, SP8). Concurrently, perform RNA-sequencing to determine the transcriptomic consequences of [RPL21P19](/details-gene/641293) loss, with a specific focus on the expression levels of `RPL21` and other ribosomal protein genes, as well as key T-cell developmental transcription factors like `GATA3` and `BCL11B`. A significant alteration in developmental progression or the expression of these key genes would provide strong evidence for a functional role. ### Therapeutic Potential At present, the therapeutic potential of [RPL21P19](/details-gene/641293) is speculative. As it is expressed in a normal developmental cell type, targeting it could have on-target, off-tumor toxicities. However, if its function is proven to be critical for T-cell proliferation, it could emerge as a potential target in T-cell acute lymphoblastic leukemia (T-ALL), where malignant thymocytes exhibit uncontrolled proliferation. In such a context, therapeutic strategies like antisense oligonucleotides (ASOs) designed to degrade the [RPL21P19](/details-gene/641293) transcript could be explored as a potential means of **inhibition** to curb malignant cell growth.